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Abstract
Helicobacter pylori is the primary cause of gastric cancer. However, monoclonal Epstein-Barr 
virus (EBV) nucleic acid is also present in up to 10% of these tumors worldwide. EBV prevalence 
is increased with male sex, non-antral localization and surgically disrupted anatomy. To further 
examine associations between EBV and gastric cancer, we organized an international consortium 
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of 11 studies with tumor EBV status assessed by in situ hybridization. We pooled individual-level 
data on 2,648 gastric cancer patients, including 184 (7%) with EBV-positive cancers; all studies 
had information on cigarette use (64% smokers) and 9 had data on alcohol (57% drinkers). We 
compared patients with EBV-positive and EBV-negative tumors to evaluate smoking and alcohol 
interactions with EBV status. To account for within-population clustering, multi-level logistic 
regression models were used to estimate interaction odds ratios (OR) adjusted for distributions of 
sex (72% male), age (mean 59 years), tumor histology (56% Lauren intestinal-type), anatomic 
subsite (61% noncardia) and year of diagnosis (1983–2012). In unadjusted analyses, the OR of 
EBV positivity with smoking was 2.2 (95% confidence interval [CI], 1.6–3.2). The OR was 
attenuated to 1.5 (95% CI, 1.01–2.3) by adjustment for the possible confounders. There was no 
significant interaction of EBV status with alcohol drinking (crude OR, 1.4; adjusted OR, 1.0). Our 
data indicate the smoking association with gastric cancer is stronger for EBV-positive than EBV-
negative tumors. Conversely, the null association with alcohol does not vary by EBV status. 
Distinct epidemiologic characteristics of EBV-positive cancer further implicate the virus as a co-
factor in gastric carcinogenesis.
Keywords
Alcohol; EBV; gastric cancer; smoking; pooled-analysis
INTRODUCTION
Although chronic Helicobacter pylori infection is the primary cause of gastric cancer,1 up to 
10% of these tumors contain nucleic acid of the Epstein-Barr virus (EBV),2 a carcinogenic 
agent implicated in the etiology of Burkitt lymphoma and nasopharyngeal carcinoma 
(NPC).3 Tumor cells of EBV-positive gastric cancer uniformly have monoclonal viral 
episomes,4 indicating the virus was present at the time of initial transformation and is 
required for maintenance of the transformed phenotype. These molecular features suggest 
that EBV coinfection may play a role in gastric carcinogenesis. To examine epidemiologic 
associations between EBV and gastric cancer with sufficient statistical power, we have 
organized an international consortium of multiple case series and case-control studies with 
assessment of tumor EBV status by in situ hybridization.
Etiologic heterogeneity of tumor subtypes (e.g., classified by histology, anatomical location 
or molecular characteristics) is frequently evaluated in case-control comparisons of potential 
risk factors in which each subtype is compared with a common control group. However, 
Begg and Zhang5 have demonstrated that the most efficient way to identify etiologic 
heterogeneity is by directly comparing risk profiles of the subtypes in a case-only study 
design. Following this analytical approach, we compared smoking and alcohol behaviors 
between patients with EBV-positive and EBV-negative gastric cancers to identify potential 
differences in risk associations.
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METHODS
Data sources
We pooled individual-level data of 11 gastric cancer case series and case-control studies 
from Asia (n=5),6–10 Europe (n=2),11, 12 and Latin America (n=4; the Mexican study at 
IMSS is ongoing),13–15 including three that have previously published data on associations 
of tumor EBV positivity with smoking and alcohol.6, 9, 13 On a total of 2,648 patients 
diagnosed between 1983 and 2012, of whom 184 (7%) had EBV-positive tumors, we 
included data on cigarette smoking, alcohol consumption, and potential confounders. For all 
cases, the presence of EBV in cancer cells was assessed by in situ hybridization for EBV-
encoded RNA (EBER), the gold standard assay for detecting latent infection.16 For the cases 
from Mexico City at IMSS, EBER expression in formalin-fixed paraffin-embedded tumors 
(as tissue microarrays, with inclusion of known EBER-positive and -negative tumors as 
controls) was detected with an automated method, as previously described.15 For the 
remaining case series, EBV results were previously reported based on the same automated 
method or a manual staining method that has shown excellent agreement in validation 
work.15 Each contributing study received local institutional review board approval, and 
written informed consent was obtained for all study participants.
Statistical analyses
In this case-only analysis, logistic regression models including a study-specific random 
intercept were used to separately estimate summary odds ratios (OR) with 95% confidence 
intervals (CI) of tumor EBV positivity with cigarette smoking (available for all 11 studies) 
and with alcohol consumption (available for 9 studies which included 134 of the EBV-
positive cases). These exposures were categorized as current and former or ever vs. never 
since quantitative data were not consistently available. The interaction OR derived from this 
case-only analytic approach is the same parameter as the ratio of the subtype-specific ORs 
from case-control comparisons.5 ORs were adjusted in multivariable models including age 
at diagnosis (categorized as quartiles), sex (male vs. female), year of diagnosis (categorized 
as quartiles), anatomic subsite (cardia, noncardia, overlapping subsites, unspecified or 
surgical stump), and Lauren histologic type (intestinal, diffuse, mixed or unspecified). For 
studies using the Japanese histological classifications, tubular, papillary and mucinous 
adenocarcinomas were considered intestinal-type, and poorly differentiated adenocarcinoma, 
signet-ring cell carcinoma and lymphoepithelioma-like carcinoma were considered diffuse-
type.17 Fifty-seven percent of cases (n=1515; six studies) also had information on level of 
education, which was used for a sensitivity analysis. All p-values were two-sided, and a 
value less than 0.05 was considered statistically significant. Statistical analyses were 
performed in Stata (version 10; Stata Corp, College Station, Texas, U.S.).
RESULTS
For the patients with EBV-positive and EBV-negative tumors combined, mean age at 
diagnosis was 59 years and 72% were males (Table 1). Sixty-four percent of patients ever 
smoked cigarettes and 57% ever drank alcohol. Most of the tumors were localized to 
noncardia subsites (61%), and classified histologically as Lauren intestinal-type (56%).
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In unadjusted analysis, the interaction OR of EBV status with ever smoking was 2.2 (95% 
CI, 1.6–3.2), and did not substantially differ between current and former use (ORs, 2.4 and 
2.0, respectively). The OR was attenuated to 1.5 (95% CI, 1.01–2.3; p=0.04) by adjustment 
for the potential confounders. Restricting to the six studies with data on level of education, 
adjusted ORs were 1.7 (95% CI, 0.8–3.6) with, and 1.6 (95% CI, 0.8–3.5) without, further 
adjustment for this variable.
The crude interaction OR of EBV status with alcohol consumption was 1.4 (95% CI, 0.9–
2.0) and remained non-significant in multivariable models with (adjusted OR, 1.1, 95% CI, 
0.7–1.7) and without (adjusted OR, 1.0, 95% CI, 0.7–1.6) inclusion of smoking.
Regarding additional covariables, sex, histologic subtype, and anatomic subsite were 
statistically significant determinants of tumor EBV positivity (Figure). Specifically, tumors 
in males and with diffuse- or mixed-type histology were more likely to be EBV-positive. As 
compared to tumors localized to the cardia, tumors arising in noncardia sites had similar 
prevalence of EBV, whereas tumors of overlapping subsites or post-gastrectomy remnants 
had increased EBV prevalence. EBV positivity did not significantly differ by age or year of 
diagnosis. In general, these unadjusted association patterns remained in all multivariable 
models.
DISCUSSION
Cigarette smoking is a recognized risk factor for gastric cancer overall.18–20 In our case-only 
analysis, we found variation of the smoking association by tumor EBV status, implying their 
interaction in gastric carcinogenesis. Three previous studies addressing this etiologic 
heterogeneity, and encompassed in the present aggregated analysis, found non-significant 
variations based on small numbers of EBV-positive tumors.6, 9, 13
A meta-analysis of 18 international prospective studies of gastric cancer found significant 
summary relative risks of 1.6 for current smokers and 1.3 for former smokers, both 
compared with never smokers.19 Given this difference in risk for gastric cancer overall, our 
finding of a 1.5-fold interaction with EBV status indicates that EBV-positive gastric cancer 
is 2.4 times more frequent in current smokers and 2.0 times more frequent in former 
smokers.
The mechanisms underlying higher gastric cancer risk for smokers are incompletely 
elucidated. Tobacco carcinogens may directly damage the gastric mucosa21 and, indirectly, 
smoking may favor H. pylori infection persistence22 and diminish efficacy of anti-H. pylori 
eradication treatment.23 Alternatively, the interaction of smoking with EBV-positive gastric 
cancer may be mediated by EBV reactivation. Cigarette smoke extract induces EBV 
reactivation in the EBV-positive cell lines Akata and B95-8.24 Smoking is also associated 
with risk of NPC, another EBV-associated malignancy, as well as with immunoglobulin A 
antibodies to the EBV viral capsid antigen in subjects without NPC.24 In addition, smoking 
is associated with risk of EBV-positive, although not EBV-negative, Hodgkin lymphoma.25
Regarding an association with alcohol consumption, we found no heterogeneity by tumor 
EBV status. The potential role of alcohol in gastric carcinogenesis is still uncertain.20 An 
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international meta-analysis of the association between alcohol drinking and gastric cancer 
found a significantly increased risk only with heavy consumption (≥4 drinks per day).26 A 
meta-analysis restricted to Latin American populations27 found an increased risk of gastric 
cancer in drinkers overall compared to never drinkers, which may be related to greater 
alcohol consumption and/or differences in the type of alcohol consumed in the Americas as 
compared to other parts of the world.28 Unfortunately, we could not rule out an effect 
restricted to heavy drinking because data on amount and frequency of alcohol consumption 
was available only for a limited number of cases. Future studies of EBV-positive gastric 
cancer should assess possible quantitative associations with alcohol consumption.
Gastric cancer is more common in developing countries, 29 and risk in both high and low 
incidence areas is inversely associated with markers of socioeconomic status (SES), such as 
level of education.30 In a subset of studies for which data on education were available, 
further adjustment for this variable did not materially change the magnitude of the 
association with smoking. Thus, the association that we found between tumor EBV status 
and smoking likely would not be explained by confounding with SES.
We found that smoking disproportionally increases the risk of EBV-positive gastric cancer. 
Previous reports have indicated that EBV-positive gastric tumors tend to be proximally 
located, account for a greater proportion of cases in males than in females, are found more 
commonly in surgically disrupted anatomy,2, 31, 32 and have a better overall survival as 
compared to EBV-negative tumors.33 Also, elevated titers against proteins related to EBV 
reactivation have been shown to precede development of premalignant34 and malignant 
gastric lesions,35 or are associated with EBV-positive gastric cancer.36, 37 Taken together, the 
combined epidemiologic evidence supports an etiologic role of EBV as a co-factor in gastric 
carcinogenesis. Our finding also warrants lifestyle modifications to reduce smoking in post-
gastrectomy patients, and other populations at high risk of EBV-positive gastric tumors.
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WHAT IS NEW?
While chronic Helicobacter pyloriinfection is the primary cause of gastric cancer, 
Epstein-Barr virus (EBV) nucleic acid is present in a subset of these tumors. EBV-
positive gastric cancer is differentially associated with smoking, but not associated with 
alcohol consumption. These behavioral data add to previous studies by us and others 
identifying demographic, clinicopathological and genetic features that distinguish EBV-
positive and EBV-negative gastric cancers. Taken together, this evidence suggests an 
etiologic role of EBV as a co-factor in gastric carcinogenesis. Our findings provide 
additional rationale for cigarette cessation in population groups at high risk of EBV-
positive gastric cancer.
Camargo et al. Page 9



















AH Formatter V6.2 MR6 (Evaluation)  http://www.antennahouse.com/
Figure 1. 
Figure Unadjusted odds ratios and 95% confidence intervals for the associations of sex, 
subsite, histologic type, age and year of diagnosis with gastric tumor EBV-positivity
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